In prostate cancer, specific imaging using positron emission tomography (PET)/computed tomography (CT)(PET/CT) with the prostate-specific membrane antigen (PSMA) can be used to detect the extent of the tumor and metastases. This evidence concerns the gene FOLH1 and prostate cancer.